Background: Robotic surgery has been a revolution for colon cancer (CC) patients, with the increasing availability of different competitive robotic systems, but evidence of relevant oncologic outcomes is indeed scarce. Our goal was to compare the surgical quality and short-term oncologic outcomes of the Kangduo Surgical Robotic System and the da Vinci Si Robotic System in patients with CC. Methods: These are results from a subcohort of a multicenter randomized controlled noninferiority trial performed in three centers in China. Enrolled patients were randomly assigned to undergo surgery using either the KD-SR-01 system (KD group) or the da Vinci Si (DV) robotic system (DV group). Neither investigators nor patients were masked to treatment allocation, but assessment of pathological outcomes was masked to treatment allocation. The primary endpoint was surgical success rate. The secondary endpoints were surgical outcomes, pathologic outcomes, and postoperative outcomes. The study is registered at www.chictr.org.cn (ChiCTR2200063172). Although the long-term follow-up results were not a predefined endpoint for this study, late-stage work is in progress. Results: A total of 58 CC patients were included in this study, 28 in the KD group and 30 in the DV group. All patients were successfully operated without any intermediate open/conventional laparoscopic surgery and the success rate of surgery was 100%. Assessment of equipment docking task load and intraoperative operating sensation score were similar between the two groups. Adverse events and Clavien–Dindo grade II or higher grade complication rates were comparable between the two groups. Device arm docking time, robotic arm operation time, and intraoperative bleeding were not significantly different between the two groups. Similar results were obtained from postoperative pathological outcomes and internal environment indexes. Conclusions: The efficacy and safety of the Kangduo Robotic Surgical System has been proved, operation of the Kangduo Robotic System by experienced surgeons for CC is not less effective than the da Vinci robotic System.
Currently, young colon cancer (CC) patients continue to increase and represent a heterogeneous patient group. The aim of this study was to explore the optimal minimum lymph node count after CC resection for young patients. We performed a comprehensive search of the Surveillance, Epidemiology, and End Results (SEER) database, 2360 CC patients aged from 20 to 40 were analyzed. X-tile was used to determine the optimal cut-off point of lymph node based on survival outcomes of young patients. The cancer specific survival (CSS) was estimated with Kaplan-Meier method, the Cox proportional hazards regression model was used to analyse independent prognostic factors and exact 95% confidence intervals (CIs). Using X-tile analysis, 22-node measure was identified as the optimal choice for CC patients aged < 40. The 5-year CSS were 85.8% and 80.9% for patients examining ≥22 nodes and < 22 nodes. Furthermore, we identified that examining < 22 nodes was an independent adverse prognostic factor in patients aged < 40. In addition, the revised 22-node measure could examine more positive nodes than the standard 12-node measure in young patients. For young colon cancer patients, the lymph node examination should be differently evaluated. We suggest that 22-node measure may be more suitable for CC patients aged < 40. Retrospectively registered.
Background: The efficacy and safety of the Kangduo (KD) robotic system in colorectal cancer (CRC) surgery are well established. However, its short-term impact on surgical stress response has not been evaluated. Materials and Methods: This study conducted a post hoc analysis of a previous non-inferiority randomized controlled trial. Patients with stage I–III CRC who underwent robotic-assisted radical CRC surgery between July 2022 and May 2023 were randomized 1:1 to the KD or da Vinci (DV) group. The primary outcomes were changes in systemic stress response markers, including alanine aminotransferase, aspartate aminotransferase, white blood cell count, hemoglobin, neutrophil count, albumin, creatinine, blood urea nitrogen, lymphocyte count, C-reactive protein, prealbumin, and the neutrophil-to-lymphocyte ratio. Results: A total of 101 patients were assessed for eligibility, and then 100 patients were enrolled (KD: n = 50; DV: n = 50). No significant differences in stress response marker trajectories were observed between the groups (all P ≥ 0.05). Subgroup analysis of complication-free patients yielded consistent results. Conclusion: Kangduo robotic-assisted CRC surgery induces systemic stress response changes comparable to those observed with the da Vinci.
12 January 2026 in International Journal of Surgery
Purpose: Although robotic surgery has advanced minimally invasive techniques, its ergonomic limitations pose significant musculoskeletal risks to surgeons. This study evaluated whether the Kangduo SR-01 (KD) open console system mitigates intraoperative ergonomic strain while preserving technical performance during robotic colorectal resection. Methods: This study utilized data from a multicenter randomized controlled non-inferiority trial comparing the efficacy and safety of KD versus Da Vinci (DV) robotic systems in assisting colorectal cancer resection. The assessment framework included ergonomic strain (Borg CR-10 Scale), team coordination (Oxford NOTECHS II), and blinded video-based technical performance analysis [Objective Structured Assessment of Technical Skills (OSATS)]. Results: A total of 100 patients were included in the modified intention-to-treat analysis: 50 in the KD group and 50 in the DV group. Body mass index (BMI) and resection types were comparable between groups. Postural demands were significantly higher for neck and back during DV procedures. Discomfort increased significantly more over time (up to 3 h) in the DV group for both neck [MD (95% c.i.) −0.889 (−1.077, −0.701), P < 0.001] and back [MD (95% c.i.) −0.606 (−0.847, −0.364), P < 0.001]. Notably, both systems achieved equivalent technical proficiency (OSATS total: 29.0 vs. 29.0, P = 0.259) and team coordination (NOTECHS II: 74.0 vs. 73.0, P = 0.120) with comparable short-term outcomes. Conclusions: The Kangduo SR-01 open console system significantly alleviated musculoskeletal strain, particularly in the neck and back, during robotic colorectal surgery while maintaining equivalent technical performance. These findings position open console platforms as a viable solution to ergonomic challenges in robotic surgery without compromising team dynamics or procedural efficiency.
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.